NEA

Pfizer, NEA back Cydan II’s plans to launch a fresh slate of biotech startups focused on rare genetic diseases
Endpoints
Wed, 10/18/17 - 08:45 am
Pfizer
NEA
Cydan
biotech
Top biotech investor NEA outlines plans for another $2.5B-plus venture fund
Fierce Biotech
Thu, 01/15/15 - 09:11 am
NEA
biotech
David Mott
venture capital
Novartis, NEA join $188M gamble on China biotech fund
Fierce Biotech
Wed, 04/9/14 - 11:51 am
China
NEA
Novartis
NEA leads $16M round for drug-eluting balloon firm
Tue, 10/4/11 - 08:05 pm
NEA
drug-eluting
funding